130 related articles for article (PubMed ID: 26329494)
1. Diagnostic performances of [18F]fluorocholine positron emission tomography in brain tumors.
Sollini M; Sghedoni R; Erba PA; Cavuto S; Froio A; De Berti G; Pisanello A; Fraternali A; Iori M; Iaccarino C; Iori M; Asti M; Filice A; Versari A
Q J Nucl Med Mol Imaging; 2018 Jun; 62(2):209-219. PubMed ID: 26329494
[TBL] [Abstract][Full Text] [Related]
2. 18F-fluoroethylcholine (18F-Cho) PET/MRI functional parameters in pediatric astrocytic brain tumors.
Fraioli F; Shankar A; Hargrave D; Hyare H; Gaze MN; Groves AM; Alongi P; Stoneham S; Michopoulou S; Syed R; Bomanji JB
Clin Nucl Med; 2015 Jan; 40(1):e40-5. PubMed ID: 25188640
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET/CT in primary brain lymphoma.
Albano D; Bosio G; Bertoli M; Giubbini R; Bertagna F
J Neurooncol; 2018 Feb; 136(3):577-583. PubMed ID: 29147860
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of metastatic and nonmetastatic skeletal findings with dual-phase 18F-FECH PET/CT in patients with biochemical relapse of prostate cancer.
Haroon A; Syed R; Endozo R; Allie R; Freeman A; Emberton M; Bomanji J
Nucl Med Commun; 2017 May; 38(5):407-414. PubMed ID: 28379896
[TBL] [Abstract][Full Text] [Related]
5. Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography/CT in Prediction of Uterine Risk Factors and Lymph Node Metastasis: An Analysis of 111 Endometrioid Endometrial Cancer Patients.
Konuralp Atakul B; Taşkın S; Soydal Ç; Sükür YE; Kahraman A; Koyuncu K; İbiş E; Ortac F
Gynecol Obstet Invest; 2017; 82(4):340-348. PubMed ID: 27771729
[TBL] [Abstract][Full Text] [Related]
6. Promising role of [18F] fluorocholine PET/CT vs [18F] fluorodeoxyglucose PET/CT in primary brain tumors-early experience.
Lam WW; Ng DC; Wong WY; Ong SC; Yu SW; See SJ
Clin Neurol Neurosurg; 2011 Feb; 113(2):156-61. PubMed ID: 21036467
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of (18)F-fluorocholine positron-emission tomography/computed tomography (PET/CT) in biochemical relapse of prostate cancer after radical treatment: results of a multicentre study.
Rodado-Marina S; Coronado-Poggio M; García-Vicente AM; García-Garzón JR; Alonso-Farto JC; de la Jara AC; Maldonado-Suárez A; Rodríguez-Fernández A
BJU Int; 2015 Jun; 115(6):874-83. PubMed ID: 25307619
[TBL] [Abstract][Full Text] [Related]
8. The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study.
Cokmert S; Tanriverdi O; Karapolat I; Demir L; Bayoglu V; Can A; Akyol M; Yilmaz Y; Oktay Tarhan M
J BUON; 2016; 21(6):1410-1418. PubMed ID: 28039701
[TBL] [Abstract][Full Text] [Related]
9. Determining the Diagnostic Value of 18F-Fluorodeoxyglucose Positron Emission/Computed Tomography in Detecting Prosthetic Aortic Graft Infection.
Mitra A; Pencharz D; Davis M; Wagner T
Ann Vasc Surg; 2018 Nov; 53():78-85. PubMed ID: 30012456
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET/CT findings in endometrial cancer patients: the correlation between SUVmax and clinicopathologic features.
Boonya-ussadorn T; Choi WH; Hyun J; Kim SH; Chung SK; Yoo IeR
J Med Assoc Thai; 2014 Feb; 97 Suppl 2():S115-22. PubMed ID: 25518184
[TBL] [Abstract][Full Text] [Related]
11. 18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study.
Cassou-Mounat T; Balogova S; Nataf V; Calzada M; Huchet V; Kerrou K; Devaux JY; Mohty M; Talbot JN; Garderet L
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1995-2004. PubMed ID: 27121691
[TBL] [Abstract][Full Text] [Related]
12. The usefulness of 18F-fluorocholine PET/CT in the detection of recurrence of central nervous system primary neoplasms.
Montes A; Fernández A; Camacho V; de Quintana C; Gallego O; Craven-Bartle J; López D; Molet J; Gómez-Ansón B; Carrió I
Rev Esp Med Nucl Imagen Mol; 2017; 36(4):227-232. PubMed ID: 28219644
[TBL] [Abstract][Full Text] [Related]
13. Distribution patterns of 18F-labelled fluoromethylcholine in normal structures and tumors of the head: a PET/MRI evaluation.
Mertens K; Ham H; Deblaere K; Kalala JP; Van den Broecke C; Slaets D; De Vos F; Goethals I
Clin Nucl Med; 2012 Aug; 37(8):e196-203. PubMed ID: 22785527
[TBL] [Abstract][Full Text] [Related]
14. Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer?
Deantonio L; Caroli A; Puta E; Ferrante D; Apicella F; Turri L; Sacchetti G; Brambilla M; Krengli M
Radiat Oncol; 2018 Oct; 13(1):211. PubMed ID: 30359275
[TBL] [Abstract][Full Text] [Related]
15.
Haroon A; Ahmed HU; Cathcart P; Almuhaideb A; Kayani I; Dickson J; Kirkham A; Freeman A; Emberton M; Bomanji J
AJR Am J Roentgenol; 2016 Dec; 207(6):1297-1306. PubMed ID: 27611962
[TBL] [Abstract][Full Text] [Related]
16. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
17. Comparison of effects of 18F-FDG PET-CT and MRI in identifying and grading gliomas.
Song PJ; Lu QY; Li MY; Li X; Shen F
J Biol Regul Homeost Agents; 2016; 30(3):833-838. PubMed ID: 27655507
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic importance of 18F-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions.
Ciftci E; Turgut B; Cakmakcilar A; Erturk SA
Nucl Med Commun; 2017 Sep; 38(9):788-794. PubMed ID: 28692494
[TBL] [Abstract][Full Text] [Related]
19. Solitary brain lesions enhancing at MR imaging: evaluation with fluorine 18 fluorocholine PET.
Kwee SA; Ko JP; Jiang CS; Watters MR; Coel MN
Radiology; 2007 Aug; 244(2):557-65. PubMed ID: 17581887
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of 18F-FDG positron emission tomography for detection and treatment control of malignant germ cell tumors.
Tsatalpas P; Beuthien-Baumann B; Kropp J; Manseck A; Tiepolt C; Hakenberg OW; Burchert W; Franke WG; Wirth MP
Urol Int; 2002; 68(3):157-63. PubMed ID: 11919460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
